Compare EVER & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVER | ETON |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 604.2M | 689.8M |
| IPO Year | 2018 | 2018 |
| Metric | EVER | ETON |
|---|---|---|
| Price | $15.79 | $22.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $27.00 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 605.3K | 386.3K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 198.86 | N/A |
| EPS | ★ 2.63 | N/A |
| Revenue | ★ $163,349,000.00 | $79,950,000.00 |
| Revenue This Year | $14.73 | $40.90 |
| Revenue Next Year | $11.51 | $47.23 |
| P/E Ratio | $5.79 | ★ N/A |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $13.93 | $13.09 |
| 52 Week High | $28.73 | $27.29 |
| Indicator | EVER | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 48.65 | 46.81 |
| Support Level | $15.09 | $16.23 |
| Resistance Level | $16.56 | $27.29 |
| Average True Range (ATR) | 0.83 | 1.07 |
| MACD | 0.07 | -0.63 |
| Stochastic Oscillator | 38.44 | 10.87 |
EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.